Total Payments
$4,513
2024 Payments
$976.38
Companies
45
Transactions
362
Medicare Patients
5,131
Medicare Billing
$458,258
Payment Breakdown by Category
Food & Beverage$4,513 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,513 | 362 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $551.81 | 62 | $0 (2024) |
| Novo Nordisk Inc | $477.26 | 34 | $0 (2024) |
| Amgen Inc. | $400.68 | 31 | $0 (2024) |
| ABBVIE INC. | $391.26 | 28 | $0 (2024) |
| Lilly USA, LLC | $333.47 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $261.73 | 24 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $205.75 | 16 | $0 (2024) |
| Allergan, Inc. | $172.64 | 16 | $0 (2020) |
| Mylan Specialty L.P. | $164.94 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $155.58 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $976.38 | 61 | Novo Nordisk Inc ($176.54) |
| 2023 | $696.31 | 50 | AbbVie Inc. ($229.79) |
| 2022 | $174.77 | 13 | Amgen Inc. ($29.28) |
| 2021 | $391.72 | 30 | Amgen Inc. ($45.15) |
| 2020 | $272.94 | 21 | Novo Nordisk Inc ($39.07) |
| 2019 | $542.23 | 49 | PFIZER INC. ($110.89) |
| 2018 | $696.44 | 60 | Amgen Inc. ($173.25) |
| 2017 | $762.53 | 78 | PFIZER INC. ($136.88) |
All Payment Transactions
362 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: VACCINES | ||||||
| 12/05/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: Obesity | ||||||
| 12/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Diabetes | ||||||
| 11/08/2024 | Braintree Laboratories, Inc. | SUFLAVE (Drug), SUTAB | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: GI COLON PREP | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Cardio-renal | ||||||
| 11/01/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Obesity | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/20/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $16.18 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/05/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $18.19 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/05/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Cardio-renal | ||||||
| 09/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: RESPIRATORY | ||||||
| 08/30/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.35 | General |
| Category: PSYCHIATRY | ||||||
| 08/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Inflammation | ||||||
| 08/01/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: Diabetes Care | ||||||
| 08/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 960 | 1,450 | $276,657 | $107,277 |
| 2022 | 18 | 1,533 | 1,985 | $297,750 | $128,002 |
| 2021 | 17 | 1,434 | 2,004 | $269,772 | $120,358 |
| 2020 | 16 | 1,204 | 1,715 | $261,776 | $102,621 |
Total Patients
5,131
Total Services
7,154
Medicare Billing
$458,258
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 366 | 751 | $120,160 | $58,625 | 48.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 152 | 195 | $23,400 | $10,825 | 46.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 49 | 53 | $11,660 | $6,390 | 54.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 68 | 69 | $6,900 | $4,956 | 71.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 24 | 24 | $36,936 | $4,420 | 12.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 18 | 21 | $10,920 | $4,389 | 40.2% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 20 | 20 | $18,420 | $3,334 | 18.1% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 11 | 11 | $9,361 | $3,097 | 33.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 71 | 72 | $2,160 | $2,061 | 95.4% |
| 11302 | Shaving of skin growth of body, arms, or legs, 1.1-2.0 cm | Office | 2023 | 18 | 19 | $3,629 | $1,795 | 49.5% |
| 11312 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm | Office | 2023 | 13 | 14 | $3,248 | $1,432 | 44.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 28 | 33 | $3,795 | $1,249 | 32.9% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 12 | 12 | $15,156 | $1,238 | 8.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 12 | 29 | $4,060 | $1,060 | 26.1% |
| 11311 | Shaving of skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm | Office | 2023 | 12 | 12 | $2,352 | $824.00 | 35.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 22 | 22 | $660.00 | $629.86 | 95.4% |
| 90715 | Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | Office | 2023 | 16 | 16 | $1,520 | $388.75 | 25.6% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 37 | $1,480 | $341.12 | 23.0% |
| 90471 | Administration of vaccine | Office | 2023 | 16 | 16 | $480.00 | $166.21 | 34.6% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 21 | 24 | $360.00 | $55.20 | 15.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 352 | 703 | $112,480 | $54,000 | 48.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 330 | 331 | $26,560 | $22,664 | 85.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 169 | 214 | $25,680 | $12,026 | 46.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 361 | 362 | $10,825 | $9,856 | 91.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 50 | 64 | $14,080 | $7,889 | 56.0% |
About Dr. Scott Stine, M.D
Dr. Scott Stine, M.D is a Family Medicine healthcare provider based in Vincennes, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457329245.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Scott Stine, M.D has received a total of $4,513 in payments from pharmaceutical and medical device companies, with $976.38 received in 2024. These payments were reported across 362 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($4,513).
As a Medicare-enrolled provider, Stine has provided services to 5,131 Medicare beneficiaries, totaling 7,154 services with total Medicare billing of $458,258. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Vincennes, IN
- Active Since 03/09/2006
- Last Updated 09/10/2014
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1457329245
Products in Payments
- VRAYLAR (Drug) $169.66
- JARDIANCE (Drug) $165.11
- CHANTIX (Drug) $160.53
- TRULICITY (Drug) $152.56
- Rybelsus (Drug) $126.34
- FARXIGA (Drug) $125.51
- Wegovy (Drug) $119.86
- Saxenda (Drug) $112.03
- YUPELRI (Drug) $108.29
- Ozempic (Drug) $107.99
- EVENITY (Biological) $103.32
- UBRELVY (Drug) $92.80
- NUEDEXTA (Drug) $91.41
- Repatha (Biological) $88.91
- TRINTELLIX (Drug) $81.51
- VIAGRA (Drug) $77.35
- LYRICA (Drug) $74.72
- XARELTO (Drug) $74.12
- MOUNJARO (Drug) $71.34
- XIFAXAN (Drug) $70.62
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Vincennes
Jane Bridges, M.d, M.D
Family Medicine — Payments: $91,349
Family Medicine $91,349
Dr. Heather Ludwig Akers
Family Medicine — Payments: $8,654
Family Medicine $8,654
Michael Kelly, Md, MD
Family Medicine — Payments: $6,536
Family Medicine $6,536
Kristin Mahan, Md, MD
Family Medicine — Payments: $5,841
Family Medicine $5,841
Sally Bodensteiner, M.d, M.D
Family Medicine — Payments: $5,342
Family Medicine $5,342
Daniel Herman, M.d, M.D
Family Medicine — Payments: $781.74
Family Medicine $781.74